
A drug called bevacizumab added to adjuvant chemotherapy did not improve outcomes for patients with a form of high-risk breast cancer, according to a study published in the Journal of Clinical Oncology.

A drug called palbociclib, used in combination with standard treatment, improved survival for women with hormone receptor-positive metastatic breast cancer.

Teresa Woodruff, PhD, vice chair for research in the Department of Obstetrics and Gynecology and dean of the Graduate School, has been elected to the National Academy of Medicine.

Sydney Doe, a third-year medical student, will receive an award from the American Public Health Association for her research exploring menstrual hygiene management in Chicago public high schools.

A pregnant woman’s higher blood sugar level is linked to a significantly greater long-term risk of obesity in her child – even more than a decade later.

A new Northwestern Medicine study has shown that pregnant women can safely limit their weight gain with diet and exercise interventions.

A bill based in part on research and advocacy at Northwestern amends the Illinois insurance code to require oncofertility coverage, which requires insurance to cover fertility preservation.

The Women’s Health Science Program, now in its 11th year, provides hands-on laboratory and clinical experiences to young women who are considering careers in science and medicine.

A large national study shows electively inducing labor at 39 weeks actually reduces the rate of cesarean deliveries and decreases maternal and fetal complications.

MD/PhD student Emma Gargus is engaged in research designing biomaterials for use in ovarian health and works to advocate for diversity and inclusion in medicine.